Mocaciclib

DB21730ExperimentalSmall molecule

Mocaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor. Mocaciclib has a monoisotopic molecular...

Mechanism: Pharmacologically active on Cyclin-dependent kinase 7
Curator reviewed
Formula / weight: C₃₃H₃₆FN₉O₂ · 609.71 g/mol (avg)
Code names: CDK7-IN-21

Resolves to

Compound

UNIIPZU3J2EH9ACAS2766124-39-2ChEMBLCHEMBL6068060ChEBI759978PubChem156358323

Structure

InChIKeyPDKSTEKFCWNJFC-LXFBAYGMSA-NSMILESCC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1

Targets

P50613CDK7

What you can answer from here — as of November 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Mocaciclib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account